Biodesix Inc SEC filings BDSX

Biodesix Inc has 600 filings in SEC EDGAR's recent list, going back to Jul 8, 2008. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (officer or director change). The company's fiscal year ends on December 31.

Biodesix Inc SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Nov 5, 2026 Nov 2, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K Current report
Shareholder vote results
May 20, 2026 May 19, 2026
8-K Current report
Results of operations
May 4, 2026 May 4, 2026
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K/A Amended current report
Results of operations
Jan 12, 2026 Jan 12, 2026
8-K Current report
Results of operations
Nov 3, 2025 Nov 3, 2025
8-K Current report
Other events
Oct 1, 2025 Sep 26, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Sep 15, 2025 Sep 12, 2025
8-K Current report
Other events
Sep 11, 2025 Sep 11, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Shareholder vote results
May 21, 2025 May 20, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
8-K Current report
Officer or director change
Apr 17, 2025 Apr 15, 2025
8-K Current report
Listing notice
Mar 28, 2025 Mar 24, 2025
8-K Current report
Results of operations
Mar 3, 2025 Mar 3, 2025
8-K Current report
Results of operations
Jan 10, 2025 Jan 10, 2025
8-K Current report
Results of operations
Nov 1, 2024 Nov 1, 2024
8-K Current report
Regulation FD disclosure
Aug 15, 2024 Aug 14, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
8-K Current report
Shareholder vote results
May 23, 2024 May 21, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Apr 9, 2024 Apr 5, 2024
8-K Current report
Results of operations
Mar 1, 2024 Mar 1, 2024
8-K Current report
New debt
Dec 20, 2023 Dec 15, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
8-K Current report
Results of operations
Aug 7, 2023 Aug 7, 2023
8-K Current report
Other events
Jul 26, 2023 Jul 24, 2023
8-K Current report
Officer or director change
Jun 6, 2023 May 31, 2023
8-K Current report
Shareholder vote results
May 25, 2023 May 23, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
8-K Current report
Results of operations
Mar 6, 2023 Mar 6, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 16, 2022 Dec 14, 2022
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Other events
Nov 21, 2022 Nov 16, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
8-K Current report
Results of operations
Oct 11, 2022 Oct 11, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Shareholder vote results
May 25, 2022 May 24, 2022
8-K Current report
Results of operations
May 11, 2022 May 11, 2022
8-K Current report
Material agreement, Unregistered share sale, Other events
Apr 11, 2022 Apr 7, 2022
8-K Current report
Results of operations
Mar 14, 2022 Mar 14, 2022
8-K Current report
Material agreement, Other events
Mar 7, 2022 Mar 7, 2022
8-K Current report
Results of operations
Feb 14, 2022 Feb 14, 2022
8-K Current report
Results of operations
Feb 14, 2022 Feb 14, 2022
8-K Current report
Material agreement, Other events
Jan 4, 2022 Dec 30, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 8, 2021 Dec 6, 2021
8-K Current report
Results of operations
Nov 15, 2021 Nov 15, 2021
8-K Current report
Regulation FD disclosure
Sep 9, 2021 Sep 9, 2021
8-K Current report
Results of operations
Aug 10, 2021 Aug 10, 2021
8-K Current report
Shareholder vote results
May 27, 2021 May 26, 2021
8-K Current report
Results of operations
May 11, 2021 May 11, 2021
8-K Current report
Material agreement, Agreement ended, New debt, Other events
Mar 23, 2021 Mar 19, 2021
8-K Current report
Results of operations
Mar 16, 2021 Mar 16, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Jan 8, 2021 Jan 8, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 5, 2021 Dec 31, 2020
8-K Current report
Results of operations
Dec 10, 2020 Dec 10, 2020

Showing 57 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
BDSX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Louisville, CO
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1439725

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.